Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

A large team of surgeons and organ transplant researchers affiliated with multiple institutions across the U.S. has found an association between lung transplant patients who become infected with the ...

Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Air pollution is the leading cause behind the rise in lung cancer cases among non-smokers, especially women and those living ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the immunotherapy be approved to treat adults ...